Tapewire

Nasdaq · USD

VREX

Varex Imaging Corp

Export transactions ↓
Tapewire entity
5135
SEC CIK
0001681622
Parsed reports
278

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 12, 2026 Filed Oct 14, 2026 21:51 UTC
Martinez Matthew AaronChief Legal Officer
GrantRestricted Stock Units · Derivative 5,411 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000073 · wk-form4_1792014701.xml · derivative · entry 2

Martinez Matthew Aaron · CIK 0002092269 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,411

Underlying: Common Stock · 5,411 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These three-year cliff Restricted Stock Units ("3-year RSUs") granted on October 12, 2026 are scheduled to vest on August 15, 2029. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, in the event of Closing, the 3-year RSUs will vest as described in footnote 5.

F5 · derivative.exercise_date: Upon Closing, (i) each tranche of 3-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing , (ii) the 3-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted as of Closing into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration.

F4 · derivative.expiration_date: These three-year cliff Restricted Stock Units ("3-year RSUs") granted on October 12, 2026 are scheduled to vest on August 15, 2029. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, in the event of Closing, the 3-year RSUs will vest as described in footnote 5.

F5 · derivative.expiration_date: Upon Closing, (i) each tranche of 3-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing , (ii) the 3-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted as of Closing into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration.

Read SEC document
October 12, 2026 Filed Oct 14, 2026 21:51 UTC
Martinez Matthew AaronChief Legal Officer
GrantRestricted Stock Units · Derivative 5,411 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000073 · wk-form4_1792014701.xml · derivative · entry 1

Martinez Matthew Aaron · CIK 0002092269 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,411

Underlying: Common Stock · 5,411 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These four-year Restricted Stock Units ("4-year RSUs") granted on October 12, 2026 are scheduled to vest 50% on August 15, 2028 and 50% on August 15, 2030. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, if the acquisition of the Issuer by Teledyne Technologies Incorporated, pursuant to that certain merger agreement dated August 10, 2026 (the "Merger Agreement") is consummated (the "Closing"), the 4-year RSUs will vest as described in footnote 3.

F3 · derivative.exercise_date: Upon Closing, (i) each tranche of 4-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing, (ii) the 4-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration.

F2 · derivative.expiration_date: These four-year Restricted Stock Units ("4-year RSUs") granted on October 12, 2026 are scheduled to vest 50% on August 15, 2028 and 50% on August 15, 2030. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, if the acquisition of the Issuer by Teledyne Technologies Incorporated, pursuant to that certain merger agreement dated August 10, 2026 (the "Merger Agreement") is consummated (the "Closing"), the 4-year RSUs will vest as described in footnote 3.

F3 · derivative.expiration_date: Upon Closing, (i) each tranche of 4-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing, (ii) the 4-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration.

Read SEC document
September 14, 2026 Filed Sep 15, 2026 21:44 UTC SaleCommon Stock 8,121 $18.48 $150,076.08
Disclosure

SEC source: 0001592005-26-000007 · wk-form4_1789508684.xml · nonDerivative · entry 1

Kunkel Jay K. · CIK 0001592005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,329

Read SEC document
September 11, 2026 Filed Sep 15, 2026 21:44 UTC
Maheshwari ShubhamChief Financial Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 160,944 $0.00 Strike: $13.61 $0.00
Disclosure

SEC source: 0001607969-26-000002 · wk-form4_1789508688.xml · derivative · entry 3

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 160,944 shares

Expires 2030-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 21:44 UTC
Maheshwari ShubhamChief Financial Officer
SaleCommon Stock 130,000 $18.46 $2,400,060.00
Disclosure

SEC source: 0001607969-26-000002 · wk-form4_1789508688.xml · nonDerivative · entry 2

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,972

F2 · shares: The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 21:44 UTC
Maheshwari ShubhamChief Financial Officer
Exercise / conversionCommon Stock 160,944 $13.61 $2,190,447.84
Disclosure

SEC source: 0001607969-26-000002 · wk-form4_1789508688.xml · nonDerivative · entry 1

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:29 UTC
Aranki Karen LChief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 3,974 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000071 · wk-form4_1787084953.xml · derivative · entry 3

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,975

Underlying: Common Stock · 3,974 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: These Restricted Stock Units granted on August 15, 2024 vested 50% on August 15, 2026, with the remaining 50% scheduled to vest on August 15, 2028. Vested shares will be delivered to the reporting person upon vesting.

F3 · derivative.expiration_date: These Restricted Stock Units granted on August 15, 2024 vested 50% on August 15, 2026, with the remaining 50% scheduled to vest on August 15, 2028. Vested shares will be delivered to the reporting person upon vesting.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:29 UTC
Aranki Karen LChief Human Resources Officer
Tax withholdingCommon Stock 1,145 $18.49 $21,171.05
Disclosure

SEC source: 0001681622-26-000071 · wk-form4_1787084953.xml · nonDerivative · entry 2

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,748

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:29 UTC
Aranki Karen LChief Human Resources Officer
Exercise / conversionCommon Stock 3,974 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-26-000071 · wk-form4_1787084953.xml · nonDerivative · entry 1

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,893

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 16:40 UTC SaleCommon Stock 4,510 $11.14 $50,241.40
Disclosure

SEC source: 0001592005-26-000005 · wk-form4_1774298442.xml · nonDerivative · entry 1

Kunkel Jay K. · CIK 0001592005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,450

F1 · price: All individual shares were sold at a price of $11.14

Read SEC document
February 12, 2026 Filed Feb 13, 2026 21:08 UTC GrantDeferred Stock Units · Derivative 14,947 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000027 · wk-form4_1771016879.xml · derivative · entry 1

Rosebrough Walter M Jr · CIK 0001413087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,947

Underlying: Common Stock · 14,947 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 21:07 UTC GrantDeferred Stock Units · Derivative 12,331 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000026 · wk-form4_1771016873.xml · derivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,331

Underlying: Common Stock · 12,331 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 16:07 UTC GrantDeferred Stock Units · Derivative 12,331 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000025 · wk-form4_1771016867.xml · derivative · entry 1

GUERTIN TIMOTHY E · CIK 0001217440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,331

Underlying: Common Stock · 12,331 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 16:08 UTC GrantDeferred Stock Units · Derivative 12,331 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000029 · wk-form4_1771016891.xml · derivative · entry 1

Bardwell Kathleen · CIK 0001532367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,331

Underlying: Common Stock · 12,331 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 16:08 UTC GrantDeferred Stock Units · Derivative 12,331 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000028 · wk-form4_1771016885.xml · derivative · entry 1

Kunkel Jay K. · CIK 0001592005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,331

Underlying: Common Stock · 12,331 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 21:07 UTC GrantDeferred Stock Units · Derivative 12,331 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000024 · wk-form4_1771016856.xml · derivative · entry 1

Chertoff Jocelyn D · CIK 0001701927 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,331

Underlying: Common Stock · 12,331 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 21:14 UTC Exercise / conversionDeferred Stock Units · Derivative 10,339 $0.00 $0.00
Disclosure

SEC source: 0001413087-26-000003 · wk-form4_1770671682.xml · derivative · entry 2

Rosebrough Walter M Jr · CIK 0001413087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,339 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 21:14 UTC Exercise / conversionCommon Stock 10,339 Not disclosed Not disclosed
Disclosure

SEC source: 0001413087-26-000003 · wk-form4_1770671682.xml · nonDerivative · entry 1

Rosebrough Walter M Jr · CIK 0001413087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,654

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 21:13 UTC Exercise / conversionDeferred Stock Units · Derivative 8,483 $0.00 $0.00
Disclosure

SEC source: 0001278861-26-000004 · wk-form4_1770671631.xml · derivative · entry 2

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 21:13 UTC Exercise / conversionCommon Stock 8,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001278861-26-000004 · wk-form4_1770671631.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 16:14 UTC Exercise / conversionDeferred Stock Units · Derivative 8,483 $0.00 $0.00
Disclosure

SEC source: 0001217440-26-000002 · wk-form4_1770671663.xml · derivative · entry 2

GUERTIN TIMOTHY E · CIK 0001217440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 16:14 UTC Exercise / conversionCommon Stock 8,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001217440-26-000002 · wk-form4_1770671663.xml · nonDerivative · entry 1

GUERTIN TIMOTHY E · CIK 0001217440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,777

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 16:14 UTC Exercise / conversionDeferred Stock Units · Derivative 8,483 $0.00 $0.00
Disclosure

SEC source: 0001532367-26-000002 · wk-form4_1770671647.xml · derivative · entry 2

Bardwell Kathleen · CIK 0001532367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 16:14 UTC Exercise / conversionCommon Stock 8,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001532367-26-000002 · wk-form4_1770671647.xml · nonDerivative · entry 1

Bardwell Kathleen · CIK 0001532367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 21:15 UTC Exercise / conversionDeferred Stock Units · Derivative 8,483 $0.00 $0.00
Disclosure

SEC source: 0001701927-26-000003 · wk-form4_1770671698.xml · derivative · entry 2

Chertoff Jocelyn D · CIK 0001701927 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 9, 2026 21:15 UTC Exercise / conversionCommon Stock 8,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001701927-26-000003 · wk-form4_1770671698.xml · nonDerivative · entry 1

Chertoff Jocelyn D · CIK 0001701927 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 09, 2026 Filed Feb 10, 2026 16:04 UTC Exercise / conversionDeferred Stock Units · Derivative 8,483 $0.00 $0.00
Disclosure

SEC source: 0001681622-26-000014 · wk-form4_1770757466.xml · derivative · entry 2

Kunkel Jay K. · CIK 0001592005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Read SEC document
February 09, 2026 Filed Feb 10, 2026 16:04 UTC Exercise / conversionCommon Stock 8,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-26-000014 · wk-form4_1770757466.xml · nonDerivative · entry 1

Kunkel Jay K. · CIK 0001592005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:33 UTC
Aranki Karen LChief Human Resources Officer
GrantPerformance Stock Units · Derivative 2,633 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000134 · wk-form4_1766007220.xml · derivative · entry 2

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,633

Underlying: Common Stock · 2,633 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:33 UTC
Aranki Karen LChief Human Resources Officer
GrantPerformance Stock Units · Derivative 2,155 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000134 · wk-form4_1766007220.xml · derivative · entry 1

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,510

Underlying: Common Stock · 2,155 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:34 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
GrantPerformance Stock Units · Derivative 3,134 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000136 · wk-form4_1766007237.xml · derivative · entry 2

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,134

Underlying: Common Stock · 3,134 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:34 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
GrantPerformance Stock Units · Derivative 2,565 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000136 · wk-form4_1766007237.xml · derivative · entry 1

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,178

Underlying: Common Stock · 2,565 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:33 UTC
SANYAL SUNNYDirector · President and CEO
GrantPerformance Stock Units · Derivative 18,801 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000135 · wk-form4_1766007229.xml · derivative · entry 2

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,801

Underlying: Common Stock · 18,801 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:33 UTC
SANYAL SUNNYDirector · President and CEO
GrantPerformance Stock Units · Derivative 15,394 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000135 · wk-form4_1766007229.xml · derivative · entry 1

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,075

Underlying: Common Stock · 15,394 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:34 UTC
Maheshwari ShubhamChief Financial Officer
GrantPerformance Stock Units · Derivative 5,520 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000138 · wk-form4_1766007254.xml · derivative · entry 2

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,520

Underlying: Common Stock · 5,520 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:34 UTC
Maheshwari ShubhamChief Financial Officer
GrantPerformance Stock Units · Derivative 4,515 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000138 · wk-form4_1766007254.xml · derivative · entry 1

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,354

Underlying: Common Stock · 4,515 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:34 UTC
Hartmann AndrewSVP and GM, Detectors
GrantPerformance Stock Units · Derivative 3,134 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000137 · wk-form4_1766007245.xml · derivative · entry 2

Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,134

Underlying: Common Stock · 3,134 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:34 UTC
Hartmann AndrewSVP and GM, Detectors
GrantPerformance Stock Units · Derivative 2,565 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000137 · wk-form4_1766007245.xml · derivative · entry 1

Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,178

Underlying: Common Stock · 2,565 shares

Expires not disclosed

F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.

F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 22:11 UTC
Aranki Karen LChief Human Resources Officer
GrantRestricted Stock Units · Derivative 21,875 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · derivative · entry 4

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,875

Underlying: Common Stock · 21,875 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 22:11 UTC
Aranki Karen LChief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 6,665 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · derivative · entry 3

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,666

Underlying: Common Stock · 6,665 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest.

F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 22:11 UTC
Aranki Karen LChief Human Resources Officer
Tax withholdingCommon Stock 1,923 $11.70 $22,499.10
Disclosure

SEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · nonDerivative · entry 2

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,919

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 22:11 UTC
Aranki Karen LChief Human Resources Officer
Exercise / conversionCommon Stock 6,665 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · nonDerivative · entry 1

Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
GrantRestricted Stock Units · Derivative 26,041 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · derivative · entry 6

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,041

Underlying: Common Stock · 26,041 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F6 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

F6 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 7,935 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · derivative · entry 5

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,936

Underlying: Common Stock · 7,935 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 4,664 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · derivative · entry 4

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,664 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Tax withholdingCommon Stock 5,526 $11.70 $64,654.20
Disclosure

SEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · nonDerivative · entry 3

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,341

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 7,935 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · nonDerivative · entry 2

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,867

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 4,664 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · nonDerivative · entry 1

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,932

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Includes 2,100 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
SANYAL SUNNYDirector · President and CEO
GrantRestricted Stock Units · Derivative 156,250 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000125 · wk-form4_1765577489.xml · derivative · entry 6

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,250

Underlying: Common Stock · 156,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 17:11 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 47,613 $0.00 $0.00
Disclosure

SEC source: 0001681622-25-000125 · wk-form4_1765577489.xml · derivative · entry 5

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,613

Underlying: Common Stock · 47,613 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.